Display Settings:

Items per page
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information

Results: 6

1.
Figure 6

Figure 6. From: Chemoprevention of esophageal squamous cell carcinoma.

Structures of isothiocyanates (from Stoner and Gupta, 2001).

Gary D. Stoner, et al. Toxicol Appl Pharmacol. ;224(3):337-349.
2.
Figure 1

Figure 1. From: Chemoprevention of esophageal squamous cell carcinoma.

Structures of some esophageal carcinogens (from Stoner and Gupta, 2001).

Gary D. Stoner, et al. Toxicol Appl Pharmacol. ;224(3):337-349.
3.
Figure 2

Figure 2. From: Chemoprevention of esophageal squamous cell carcinoma.

Schema for metabolic activation of NMBA (from Stoner and Gupta, 2001).

Gary D. Stoner, et al. Toxicol Appl Pharmacol. ;224(3):337-349.
4.
Figure 4

Figure 4. From: Chemoprevention of esophageal squamous cell carcinoma.

Histopathology of NMBA-induced lesions in rat esophagus (from Stoner et al., 2006).

Gary D. Stoner, et al. Toxicol Appl Pharmacol. ;224(3):337-349.
5.
Figure 5

Figure 5. From: Chemoprevention of esophageal squamous cell carcinoma.

Molecular events in papilloma development during NMBA-induced rat esophageal tumorigenesis (from Stoner and Gupta, 2001).

Gary D. Stoner, et al. Toxicol Appl Pharmacol. ;224(3):337-349.
6.
Figure 3

Figure 3. From: Chemoprevention of esophageal squamous cell carcinoma.

Appearance of rat esophageal lesions at the termination of a 25-wk bioassay. There are several papillomas on the surface of the esophagus. The lesion on the lower left was found to be a carcinoma upon histological analysis (from Stoner et al., 2006).

Gary D. Stoner, et al. Toxicol Appl Pharmacol. ;224(3):337-349.

Display Settings:

Items per page

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Write to the Help Desk